Neosynalar Crm Vet .25 mg Cream is a Health Canada–registered veterinary drug (DIN 00189480) held by Syntex Animal Health, Division Of Syntex Inc., containing Fluocinolone Acetonide. Health Canada lists its status as Cancelled Post Market (status date 22 Aug 2000). Nexara Health has matched 201 registrations of Fluocinolone Acetonide across 18 other regulated markets.
Health Canada registration
| DIN | 00189480 |
|---|---|
| Brand name | Neosynalar Crm Vet |
| Active ingredient | Fluocinolone Acetonide |
| Strength | .25 mg |
| Dosage form | Cream |
| Route | Topical |
| Company | Syntex Animal Health, Division Of Syntex Inc. |
| Status | Cancelled Post Market — 22 Aug 2000 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Fluocinolone Acetonide registered in other markets
201 registrations of the same molecule in 18 national registries outside Canada (first 69 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bahrain | Iluvien | Alimera Sciences, Inc., Usa. | 0.19 MG | Intravitreal Implant | POM | NHRA |
| Bulgaria | Abricort | Тева Фарма ЕАД | 0.25 mg/g ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Abricort | Тева Фарма ЕАД | 0,25 mg/g cream | крем | По лекарско предписание | BDA |
| Bulgaria | Flucinar | Bausch Health Ireland Limited | 0,025% ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Flucinar | Bausch Health Ireland Limited | FLUCINAR 0,025 % gel | гел | По лекарско предписание | BDA |
| Bulgaria | Procto Flinar | Galenica Pharmaceutical Industry S.A. | 0.01% /2% rectal cream | крем ректален | Без лекарско предписание | BDA |
| Czech Republic | Iluvien | — | 190MCG | Ivi Imp Apl | R | SUKL DLP |
| European Union (EMA) | Retisert | Bausch Lomb Ireland | Application withdrawn | EMA centrally authorised | ||
| Hong Kong | Cino Cream 0.025% | Europharm Lab Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Fluciderm Cream 0.025% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Flucortderm Cream 0.025% | Europharm Lab Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Flunolone V Cream 0.025% | Atlantic Pharmaceutical Limited | Registered | DH Drug Office | ||
| Hong Kong | Fluocinolone Acetonide Cream 0.025% | Europharm Lab Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Fluocinolone Acetonide Oint 0.03% | Marching Pharmaceutical Limited | Registered | DH Drug Office | ||
| Hong Kong | Fluocinolone Cream 0.005% (Vida) | Marching Pharmaceutical Limited | Registered | DH Drug Office | ||
| Hong Kong | Fluocinolone Cream 0.005%W/W | Marching Pharmaceutical Limited | Registered | DH Drug Office | ||
| Ireland | ILUVIEN 190 micrograms intravitreal implant in applicator | Alimera Sciences Europe Limited, | Intravitreal implant in applicator | Marketed | HPRA | |
| Italy | FLUOVITEF*crema derm 30 g 0,025% | TEOFARMA Srl | FLUOCINOLONE ACETONIDE 0,025% 30G POMATA USO DERMATOLOGICO | Classe A | AIFA liste A/H | |
| Italy | ILUVIEN*impianto intravitreale 190 mcg | Alimera Sciences Europe Ltd | FLUOCINOLONE ACETONIDE 190MCG 1 UNITA' USO INTRAVITREALE | Classe H | AIFA liste A/H | |
| Lebanon | Fluocinolone Acetonide | Mediphar Laboratories | 0.25mg/g | Cream | A1 | MoPH |
| Netherlands | ILUVIEN 190 microgram, intravitreaal implant in applicator | Alimera Sciences Europe Limited | Intravitreaal implant in applicator | Uitsluitend recept | EU national register | |
| Poland | Flucinar | InPharm Sp. z o.o. | 0,25 mg/g | Maść | 2027-01-18 | URPL RPL |
| Poland | Flucinar | InPharm Sp. z o.o. | 0,25 mg/g | Maść | 2029-11-19 | URPL RPL |
| Poland | Flucinar | Pretium Farm Sp. z o.o. | 0,25 mg/g | Maść | 2023-11-30 | URPL RPL |
| Poland | Flucinar | Bausch Health Ireland Ltd. | 0,25 mg/g | Maść | Bezterminowe | URPL RPL |
| Poland | Flucinar | Bausch Health Ireland Ltd. | 0,25 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Flucinar | InPharm Sp. z o.o. | 0,25 mg/g | Żel | 2031-03-03 | URPL RPL |
| Poland | Flucinar | Medezin Sp. z o.o. | 0,25 mg/g | Maść | 2029-08-22 | URPL RPL |
| Poland | Flucinar | Delfarma Sp. z o.o. | 0,25 mg/g | Maść | 2026-09-21 | URPL RPL |
| Romania | FLUOCINOLON ACETONID LAROPHARM 0,25 mg/g | — | 0,25mg/g | Unguent | PRF | ANMDMR nomenclator |
| Saudi Arabia | Dermolar | — | 0.025 | Inactive | SFDA | |
| Saudi Arabia | Dermolar | — | 0.025 | Inactive | SFDA | |
| Saudi Arabia | Petralar 0.025% Cream | — | 0.025 | Inactive | SFDA | |
| Saudi Arabia | Petralar-F 0.25% Cream | — | 0.25 | Inactive | SFDA | |
| Saudi Arabia | Synalar Cream | — | 0.025 | Inactive | SFDA | |
| Saudi Arabia | Synalar Ointment | — | 0.025 | Inactive | SFDA | |
| Singapore | SUPRICORT CREAM 0.025% w/w | Uni Drug House | 0.025% w/w | Cream | Prescription Only | HSA |
| South Africa | Cortoderm | Pharmacare Limited, Woodmead | 1.25 mg/5g | Cre | S4 | DoH SEP database |
| South Africa | Cortoderm | Pharmacare Limited, Woodmead | 1.25 mg/5g | Oin | S4 | DoH SEP database |
| South Africa | Cortoderm | Pharmacare Limited, Woodmead | 1.25 mg/5g | Oin | S4 | DoH SEP database |
| South Africa | Cortoderm | Pharmacare Limited, Woodmead | 1.25 mg/5g | Cre | S4 | DoH SEP database |
| South Africa | Synalar | Glenmark Pharmaceuticals South Africa (Pty) Ltd | mg/g | Oin | S4 | DoH SEP database |
| South Africa | Synalar | Glenmark Pharmaceuticals South Africa (Pty) Ltd | mg/g | Cre | S4 | DoH SEP database |
| South Africa | Synalar Gel | Glenmark Pharmaceuticals South Africa (Pty) Ltd | mg/g | Jel | S4 | DoH SEP database |
| Taiwan | Coderma Cream | Biotrading Co. Pharmaceutical Industry. (Biotrading Co., Laboratories) | 乳膏劑 | 已註銷 | TFDA | |
| Taiwan | Dermil Cream | C.i.f.a. Farmaceutici S.p.a. | 乳膏劑 | 已註銷 | TFDA | |
| Taiwan | Dermil Lotion | C.i.f.a. Farmaceutici S.p.a. | 洗劑 | 已註銷 | TFDA | |
| Taiwan | Esilon Pomata | Laboratorio Farmaceutico S.i.t. S.p.a. | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Flucin Cream 0.25mg/Gm "Gcpc" | 人人化學製藥股份有限公司中壢廠 | 乳膏劑 | Registered | TFDA | |
| Taiwan | Flucone Ointment | 大全榮製藥股份有限公司 | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Flucone Ointment 0.25mg/g (Fluocineolone) | 大全榮製藥股份有限公司 | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Flucont Ointment (Fluocinolone) | 健康化學製藥股份有限公司 | 軟膏劑 | Registered | TFDA | |
| United Arab Emirates | Cetraxal Plus 3 mg/ml + 0.25 mg/ml | Laboratorios Salvat, S.A, Spain, Barcelona | 3 mg/ml + 0.25 mg/ml | Drops | Active | EDE |
| United Kingdom | Fluocinolone acetonide 0.0025% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.00625% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.00625% ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.025% / Clioquinol 3% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.025% / Clioquinol 3% ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.025% / Neomycin 0.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.025% / Neomycin 0.5% ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Fluocinolone acetonide 0.025% cream | — | 0001 | NHS dm+d VMP | ||
| United States | Derma-Smoothe/Fs | Royal Pharmaceuticals | Oil | listed | FDA NDC | |
| United States | Derma-Smoothe/FS | Royal Pharmaceuticals, LLC | Oil | listed | FDA NDC | |
| United States | Dermotic | Royal Pharmaceuticals | Oil | listed | FDA NDC | |
| United States | Flac Otic Oil | Patrin Pharma, Inc. | Oil | listed | FDA NDC | |
| United States | fluocinolone acetonide | Bryant Ranch Prepack | Oil | listed | FDA NDC | |
| United States | fluocinolone acetonide | ANI Pharmaceuticals, Inc. | Cream | listed | FDA NDC | |
| United States | fluocinolone acetonide | Padagis Israel Pharmaceuticals Ltd | Oil | listed | FDA NDC | |
| United States | fluocinolone acetonide | Glenmark Pharmaceuticals Inc., USA | Oil | listed | FDA NDC |
See every manufacturer of Fluocinolone Acetonide worldwide →
Regulator price references for Fluocinolone Acetonide
Published list or reimbursement prices for Fluocinolone Acetonide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Bahrain | Iluvien | 0.19mg | 1 | 3,206.34 BHD | retail (max) | NHRA | 2026-09-01 |
| Italy | FLUOVITEF*crema derm 30 g 0,025% | 0.025pct+30000mg | FLUOCINOLONE ACETONIDE 0,025% 30G POMATA USO DERMATOLOGICO | 2.58 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Italy | ILUVIEN*impianto intravitreale 190 mcg | 0.19mg | FLUOCINOLONE ACETONIDE 190MCG 1 UNITA' USO INTRAVITREALE | 6,837.57 EUR | ex-factory (classe H) | AIFA liste A/H | 2026-09-02 |
| Lebanon | Fluocinolone Acetonide | 0.25mg/1000mg | 15g | 3.32 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Saudi Arabia | Petralar 0.025% Cream | 0.025pct | 8.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Dermolar | 9.25 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Dermolar | 9.30 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Synalar Cream | 9.65 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Synalar Ointment | 9.65 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Petralar-F 0.25% Cream | 0.25pct | 13.60 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Cortoderm | 1.25mg/5000mg | 15 | 17.66 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cortoderm | 1.25mg/5000mg | 15 | 25.29 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Synalar | 15 | 99.17 ZAR | single exit price | DoH SEP database | 2026-09-01 | |
| South Africa | Synalar | 15 | 99.17 ZAR | single exit price | DoH SEP database | 2026-09-01 | |
| South Africa | Synalar Gel | 30 | 229.22 ZAR | single exit price | DoH SEP database | 2026-09-01 | |
| South Africa | Cortoderm | 1.25mg/5000mg | 500 | 588.74 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Cortoderm | 1.25mg/5000mg | 500 | 843.32 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Cetraxal Plus 3 mg/ml + 0.25 mg/ml | 0.25mg/1ml+3mg/1ml | 15 Single-Dose Containers (0.25 ml) | 61.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Neosynalar Crm Vet (DIN 00189480) marketed in Canada?
No. Health Canada lists DIN 00189480 as Cancelled Post Market as of 22 Aug 2000.
Who holds the Canadian licence for this product?
Syntex Animal Health, Division Of Syntex Inc. is the company of record in the Health Canada Drug Product Database.
Is Fluocinolone Acetonide registered outside Canada?
Yes — Nexara Health has matched 201 registrations in 18 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00189480, status date 2000-08-22; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, MoPH, NHRA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: AIFA liste A/H, DoH SEP database, EDE, MoPH, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00189480, status date 2000-08-22; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, MoPH, NHRA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: AIFA liste A/H, DoH SEP database, EDE, MoPH, NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 00189480, status date 2000-08-22; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, MoPH, NHRA, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: AIFA liste A/H, DoH SEP database, EDE, MoPH, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.